Rapid quantification of constituents in St. John's wort extracts by NIR spectroscopy

被引:29
|
作者
Rager, I [1 ]
Roos, G [1 ]
Schmidt, PC [1 ]
Kovar, KA [1 ]
机构
[1] Univ Tubingen, Inst Pharmaceut, D-72076 Tubingen, Germany
关键词
Hypericum perforatum; St. John's wort extracts; NIR spectroscopy; RP-HPLC; quantification;
D O I
10.1016/S0731-7085(01)00602-1
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A quantitative near-infrared reflectance spectroscopy (NIRS) method was established for the determination of two major constituents (hyperforin and I3,II8-biapigenin) in St. John's wort extracts. Hyperforin was chosen due to the fact that it is found in a concentration range from I to 5%, a common one for NIRS determinations. I3,II8-Biapigenin on the other hand was selected as a constituent with very low concentrations (0.1-0.7%) but an extensive chromophore that allows very precise measurements in the ultraviolet (UV) and thus exact reference values that are vital for proper NIRS calibrations. Reference measurements were performed by reversed-phase high performance liquid chromatography (HPLC), determining the constituents' content in 35 pharmaceutical dry extracts of different origins. The reference method was validated according to the ICH guideline Q2B. Using partial-least squares (PLS) regression a multivariate calibration was done for the two ingredients each (PLS1). Satisfactory calibration statistics were obtained for hyperforin with a root mean square error of calibration (RMSEC) of 0.17 and a root mean square error of prediction (RMSEP) of 0.22 at a concentration range from I to 6% in the dry extracts. Due to the very low concentrations of I3,II8-biapigenin the accuracy of prediction is somewhat lower. However, it is possible to obtain very good results and reliable prediction by dividing the concentration range at 0.35%. The study emphasizes the potential of NIRS as a rapid and highly effective alternative method to conventional quantitative analysis of plant extracts. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:439 / 446
页数:8
相关论文
共 50 条
  • [21] Estimation of Dermatological Application of Creams with St. John's Wort Oil Extracts
    Arsic, Ivana
    Zugic, Ana
    Tadic, Vanja
    Tasic-Kostov, Marija
    Misic, Dusan
    Primorac, Marija
    Runjaic-Antic, Dusanka
    MOLECULES, 2012, 17 (01): : 275 - 294
  • [22] Pseudohypericin and hypericin in St. John's wort extracts. Breakdown of pseudohypericin
    Fourneron, JD
    Herbette, G
    Caloprisco, E
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE II FASCICULE C-CHIMIE, 1999, 2 (03): : 127 - 131
  • [23] STEPS TO ST. JOHN'S WORT FACTOR
    不详
    CHEMICAL & ENGINEERING NEWS, 2010, 88 (04) : 28 - 28
  • [24] Poisoning related to St. John's wort
    van Wuijckhuise, L
    Mars, M
    Counotte, G
    Kock, P
    TIJDSCHRIFT VOOR DIERGENEESKUNDE, 2002, 127 (16) : 499 - 499
  • [25] St. John's Wort for depressive disorders
    Müller, B
    MEDIZINISCHE WELT, 1999, 50 (07): : 307 - 310
  • [26] What Is the Place of St. John's Wort?
    Pray, W. Steven
    Pray, Gabriel E.
    US PHARMACIST, 2012, 37 (11) : 12 - 15
  • [27] St. John's Wort equal to SSRI
    Tippmann, Marianne E.
    Willich, Stefan N.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2006, 74 (11) : B4 - B4
  • [28] Delayed emergence and St. John's wort
    Crowe, S
    McKeating, K
    ANESTHESIOLOGY, 2002, 96 (04) : 1025 - 1027
  • [29] Analysis and stability of the constituents of St. John's wort oils prepared with different methods
    Isacchi, B.
    Bergonzi, M. C.
    Carnevali, F.
    van der Esch, S. A.
    Vincieri, F. F.
    Bilia, A. R.
    PLANTA MEDICA, 2007, 73 (09) : 856 - 857
  • [30] HIV stalled by St. John's Wort
    Secko, D
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (02) : 152 - 152